| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 172 | 2024 | 1124 | 12.320 |
Why?
|
| Trinucleotide Repeat Expansion | 33 | 2022 | 243 | 3.280 |
Why?
|
| Nerve Tissue Proteins | 74 | 2019 | 4463 | 3.220 |
Why?
|
| Trinucleotide Repeats | 35 | 2017 | 261 | 2.370 |
Why?
|
| Nuclear Proteins | 63 | 2015 | 5854 | 2.230 |
Why?
|
| Chromosomes, Human, Pair 4 | 53 | 2015 | 374 | 2.030 |
Why?
|
| Corpus Striatum | 25 | 2018 | 1219 | 1.600 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 26 | 2010 | 798 | 1.050 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 10 | 2012 | 142 | 1.040 |
Why?
|
| Endodeoxyribonucleases | 3 | 2024 | 165 | 0.920 |
Why?
|
| Exodeoxyribonucleases | 3 | 2024 | 180 | 0.920 |
Why?
|
| Alleles | 43 | 2021 | 6934 | 0.860 |
Why?
|
| Age of Onset | 37 | 2021 | 3268 | 0.830 |
Why?
|
| Ribonucleotide Reductases | 1 | 2020 | 77 | 0.740 |
Why?
|
| Chromosome Mapping | 39 | 2008 | 4737 | 0.670 |
Why?
|
| Haplotypes | 21 | 2020 | 2779 | 0.600 |
Why?
|
| Peptides | 21 | 2012 | 4406 | 0.550 |
Why?
|
| Neurons | 37 | 2018 | 9336 | 0.550 |
Why?
|
| Polymorphism, Genetic | 20 | 2017 | 4326 | 0.530 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2013 | 896 | 0.510 |
Why?
|
| Mutation | 47 | 2021 | 29777 | 0.510 |
Why?
|
| Crosses, Genetic | 6 | 2015 | 791 | 0.500 |
Why?
|
| Chromosomes, Mammalian | 2 | 2015 | 151 | 0.500 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1781 | 0.500 |
Why?
|
| Receptors, Dopamine | 2 | 2013 | 295 | 0.480 |
Why?
|
| Disease Models, Animal | 28 | 2020 | 18027 | 0.470 |
Why?
|
| Thiolester Hydrolases | 3 | 2006 | 86 | 0.450 |
Why?
|
| Genetic Linkage | 21 | 2021 | 2419 | 0.450 |
Why?
|
| Gene Expression Regulation | 18 | 2021 | 12066 | 0.400 |
Why?
|
| Mice, Transgenic | 25 | 2015 | 9731 | 0.390 |
Why?
|
| Heat-Shock Proteins | 2 | 2012 | 820 | 0.380 |
Why?
|
| Genetic Markers | 32 | 2006 | 2634 | 0.370 |
Why?
|
| Animals | 117 | 2021 | 168660 | 0.370 |
Why?
|
| Heterozygote | 12 | 2024 | 2803 | 0.360 |
Why?
|
| Gene Expression | 11 | 2015 | 7793 | 0.360 |
Why?
|
| Receptors, Kainic Acid | 3 | 2012 | 88 | 0.350 |
Why?
|
| Mice | 74 | 2020 | 81154 | 0.340 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 3463 | 0.330 |
Why?
|
| Phenotype | 24 | 2021 | 16361 | 0.330 |
Why?
|
| DNA Repeat Expansion | 2 | 2006 | 66 | 0.330 |
Why?
|
| Molecular Chaperones | 5 | 2011 | 742 | 0.330 |
Why?
|
| Metabolome | 1 | 2015 | 894 | 0.330 |
Why?
|
| Genes | 9 | 1999 | 1893 | 0.320 |
Why?
|
| Cerebellum | 6 | 2015 | 1487 | 0.310 |
Why?
|
| Gene Knock-In Techniques | 9 | 2018 | 418 | 0.300 |
Why?
|
| Polymorphism, Restriction Fragment Length | 21 | 2006 | 769 | 0.300 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 2018 | 0.300 |
Why?
|
| Mitochondria | 6 | 2007 | 3513 | 0.290 |
Why?
|
| Neostriatum | 5 | 2018 | 249 | 0.290 |
Why?
|
| Molecular Sequence Data | 37 | 2015 | 18107 | 0.290 |
Why?
|
| Pedigree | 25 | 2021 | 4643 | 0.280 |
Why?
|
| Humans | 224 | 2024 | 743811 | 0.270 |
Why?
|
| Cell Line | 29 | 2021 | 15993 | 0.270 |
Why?
|
| Genetic Diseases, Inborn | 4 | 2002 | 588 | 0.260 |
Why?
|
| Gastrula | 1 | 2005 | 84 | 0.260 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 2703 | 0.260 |
Why?
|
| Translocation, Genetic | 8 | 2012 | 1420 | 0.260 |
Why?
|
| Minisatellite Repeats | 3 | 2007 | 165 | 0.250 |
Why?
|
| Genotype | 23 | 2019 | 12944 | 0.240 |
Why?
|
| Neurodegenerative Diseases | 5 | 2010 | 1060 | 0.240 |
Why?
|
| Membrane Proteins | 9 | 2013 | 7880 | 0.220 |
Why?
|
| Base Sequence | 32 | 2015 | 12798 | 0.220 |
Why?
|
| Brain | 25 | 2018 | 26345 | 0.220 |
Why?
|
| Genes, Dominant | 4 | 2006 | 880 | 0.210 |
Why?
|
| Drosophila | 3 | 2014 | 1494 | 0.210 |
Why?
|
| MicroRNAs | 4 | 2024 | 3750 | 0.210 |
Why?
|
| Recombination, Genetic | 8 | 1994 | 1586 | 0.210 |
Why?
|
| Genome-Wide Association Study | 11 | 2024 | 12259 | 0.210 |
Why?
|
| Membrane Glycoproteins | 5 | 2011 | 3769 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2020 | 15518 | 0.210 |
Why?
|
| Dictyostelium | 2 | 2014 | 72 | 0.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 5 | 2007 | 604 | 0.210 |
Why?
|
| Cell Nucleus | 6 | 2006 | 2969 | 0.210 |
Why?
|
| Exons | 11 | 2024 | 2438 | 0.200 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 9440 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2007 | 4552 | 0.190 |
Why?
|
| Repressor Proteins | 2 | 2009 | 3024 | 0.190 |
Why?
|
| Molecular Biology | 3 | 2000 | 595 | 0.190 |
Why?
|
| Chromosome Breakage | 3 | 2012 | 173 | 0.190 |
Why?
|
| Body Patterning | 1 | 2005 | 629 | 0.190 |
Why?
|
| Chromosomes, Human | 4 | 2015 | 457 | 0.190 |
Why?
|
| Calcium Signaling | 1 | 2005 | 721 | 0.190 |
Why?
|
| Motor Skills Disorders | 1 | 2021 | 90 | 0.190 |
Why?
|
| Animals, Genetically Modified | 6 | 2013 | 1552 | 0.190 |
Why?
|
| Neural Stem Cells | 4 | 2017 | 851 | 0.190 |
Why?
|
| DNA | 29 | 2022 | 7295 | 0.190 |
Why?
|
| Glutamine | 2 | 2002 | 579 | 0.180 |
Why?
|
| Energy Metabolism | 3 | 2007 | 2899 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 3917 | 0.180 |
Why?
|
| Friend murine leukemia virus | 6 | 1981 | 65 | 0.180 |
Why?
|
| Karyopherins | 1 | 2000 | 137 | 0.180 |
Why?
|
| Restriction Mapping | 8 | 1996 | 878 | 0.180 |
Why?
|
| Mice, Knockout | 9 | 2020 | 14563 | 0.180 |
Why?
|
| Genomic Instability | 3 | 2015 | 695 | 0.180 |
Why?
|
| Models, Genetic | 7 | 2013 | 3492 | 0.170 |
Why?
|
| Transcription Factors | 7 | 2012 | 12209 | 0.170 |
Why?
|
| Cell Differentiation | 9 | 2019 | 11478 | 0.170 |
Why?
|
| Venezuela | 6 | 2018 | 73 | 0.170 |
Why?
|
| 3' Untranslated Regions | 4 | 2024 | 513 | 0.170 |
Why?
|
| Organelles | 2 | 2000 | 264 | 0.170 |
Why?
|
| Amino Acid Sequence | 15 | 2021 | 13809 | 0.170 |
Why?
|
| Cyclic AMP | 1 | 2003 | 1472 | 0.170 |
Why?
|
| Gene Silencing | 1 | 2005 | 1537 | 0.160 |
Why?
|
| Brain Chemistry | 5 | 2007 | 982 | 0.160 |
Why?
|
| X Chromosome | 3 | 2021 | 814 | 0.160 |
Why?
|
| Gene Targeting | 3 | 2005 | 879 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 17439 | 0.160 |
Why?
|
| Mice, Mutant Strains | 8 | 2009 | 1862 | 0.160 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 2 | 2011 | 52 | 0.160 |
Why?
|
| Male | 91 | 2021 | 349776 | 0.160 |
Why?
|
| Models, Biological | 7 | 2021 | 9582 | 0.160 |
Why?
|
| DNA Repair | 2 | 2008 | 2045 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 10 | 2021 | 4803 | 0.150 |
Why?
|
| Cells, Cultured | 16 | 2011 | 19232 | 0.150 |
Why?
|
| Cerebral Cortex | 6 | 2015 | 5692 | 0.150 |
Why?
|
| Iduronidase | 3 | 1992 | 31 | 0.150 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 2 | 2015 | 31 | 0.150 |
Why?
|
| Ubiquitins | 1 | 1999 | 384 | 0.150 |
Why?
|
| Cysteine Endopeptidases | 2 | 1999 | 563 | 0.150 |
Why?
|
| Organ Specificity | 4 | 2015 | 2008 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 2 | 2012 | 315 | 0.150 |
Why?
|
| Female | 82 | 2021 | 380020 | 0.140 |
Why?
|
| Protozoan Proteins | 2 | 2014 | 825 | 0.140 |
Why?
|
| Genes, Homeobox | 2 | 2015 | 286 | 0.140 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 322 | 0.140 |
Why?
|
| Family Health | 4 | 2018 | 1280 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2009 | 2839 | 0.140 |
Why?
|
| Homozygote | 6 | 2024 | 1787 | 0.140 |
Why?
|
| Gene Frequency | 10 | 2019 | 3585 | 0.140 |
Why?
|
| Sequence Deletion | 6 | 2006 | 1524 | 0.140 |
Why?
|
| Genes, Developmental | 1 | 2015 | 40 | 0.140 |
Why?
|
| Germ-Line Mutation | 3 | 2012 | 1787 | 0.130 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 686 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 871 | 0.130 |
Why?
|
| DNA, Complementary | 7 | 2006 | 2050 | 0.130 |
Why?
|
| Proteins | 5 | 2018 | 6098 | 0.130 |
Why?
|
| Iron | 2 | 2000 | 1774 | 0.130 |
Why?
|
| Internationality | 1 | 2021 | 1002 | 0.130 |
Why?
|
| Immunoblotting | 6 | 2011 | 1683 | 0.130 |
Why?
|
| Chromosome Aberrations | 4 | 2008 | 1811 | 0.130 |
Why?
|
| Linkage Disequilibrium | 5 | 2002 | 1996 | 0.120 |
Why?
|
| RNA, Messenger | 13 | 2021 | 13028 | 0.120 |
Why?
|
| TATA-Box Binding Protein | 3 | 2003 | 98 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2012 | 417 | 0.120 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1994 | 114 | 0.120 |
Why?
|
| Penetrance | 3 | 2015 | 381 | 0.120 |
Why?
|
| Neuropsychological Tests | 3 | 2021 | 6976 | 0.120 |
Why?
|
| Chromosome Disorders | 3 | 2012 | 510 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 3 | 2009 | 1146 | 0.120 |
Why?
|
| Edetic Acid | 1 | 2014 | 274 | 0.120 |
Why?
|
| Leukemia, Experimental | 5 | 1981 | 246 | 0.110 |
Why?
|
| Autopsy | 5 | 2017 | 1020 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 2 | 4 | 2012 | 326 | 0.110 |
Why?
|
| Spermatozoa | 6 | 2007 | 618 | 0.110 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 2 | 2006 | 48 | 0.110 |
Why?
|
| Sheep, Domestic | 1 | 2013 | 49 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2014 | 23398 | 0.110 |
Why?
|
| Mutagenesis, Insertional | 3 | 2002 | 654 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2013 | 475 | 0.110 |
Why?
|
| Transcription, Genetic | 7 | 2003 | 7719 | 0.110 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2013 | 171 | 0.110 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 351 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2017 | 518 | 0.110 |
Why?
|
| Cosmids | 7 | 1994 | 107 | 0.110 |
Why?
|
| Codon, Terminator | 1 | 2012 | 127 | 0.100 |
Why?
|
| Chorea | 2 | 2002 | 74 | 0.100 |
Why?
|
| Databases, Genetic | 2 | 2014 | 1782 | 0.100 |
Why?
|
| Cluster Analysis | 5 | 2015 | 2712 | 0.100 |
Why?
|
| Heterochromatin | 1 | 2014 | 296 | 0.100 |
Why?
|
| Genetics, Population | 2 | 2018 | 933 | 0.100 |
Why?
|
| Solubility | 4 | 2003 | 1088 | 0.100 |
Why?
|
| Embryonic Stem Cells | 3 | 2017 | 1295 | 0.100 |
Why?
|
| Precipitin Tests | 3 | 2003 | 829 | 0.100 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2013 | 245 | 0.100 |
Why?
|
| Meclizine | 1 | 2010 | 13 | 0.100 |
Why?
|
| Cell Transformation, Viral | 6 | 1987 | 566 | 0.100 |
Why?
|
| Gene Deletion | 4 | 2015 | 2749 | 0.100 |
Why?
|
| Aneuploidy | 1 | 1994 | 530 | 0.100 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2013 | 422 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 944 | 0.090 |
Why?
|
| Acetylesterase | 1 | 2010 | 14 | 0.090 |
Why?
|
| Parkinson Disease | 4 | 2008 | 2785 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 1083 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2459 | 0.090 |
Why?
|
| Adult | 46 | 2021 | 213889 | 0.090 |
Why?
|
| Gene Library | 8 | 2001 | 1074 | 0.090 |
Why?
|
| Cloning, Molecular | 11 | 1998 | 4320 | 0.090 |
Why?
|
| Cell Death | 5 | 2005 | 1705 | 0.090 |
Why?
|
| Europe | 3 | 2012 | 3336 | 0.090 |
Why?
|
| Genetic Testing | 7 | 2007 | 3439 | 0.090 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2010 | 98 | 0.090 |
Why?
|
| Genetic Variation | 7 | 2015 | 6535 | 0.090 |
Why?
|
| Serine | 2 | 2004 | 825 | 0.090 |
Why?
|
| Middle Aged | 46 | 2021 | 213241 | 0.090 |
Why?
|
| Genetic Pleiotropy | 1 | 2011 | 182 | 0.090 |
Why?
|
| Cell Adhesion | 2 | 2014 | 3144 | 0.090 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2010 | 181 | 0.090 |
Why?
|
| Nerve Degeneration | 5 | 2006 | 748 | 0.090 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 756 | 0.090 |
Why?
|
| Gliosis | 2 | 2012 | 245 | 0.090 |
Why?
|
| Potassium Channels | 1 | 2012 | 563 | 0.090 |
Why?
|
| Neuroglia | 2 | 2012 | 928 | 0.080 |
Why?
|
| Caudate Nucleus | 3 | 2012 | 392 | 0.080 |
Why?
|
| Receptors, Transferrin | 2 | 2000 | 296 | 0.080 |
Why?
|
| Golgi Apparatus | 2 | 2000 | 410 | 0.080 |
Why?
|
| Caspase 3 | 3 | 2006 | 758 | 0.080 |
Why?
|
| Neurites | 1 | 2011 | 388 | 0.080 |
Why?
|
| Crossing Over, Genetic | 3 | 1994 | 95 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2017 | 1733 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2000 | 5021 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2021 | 2256 | 0.080 |
Why?
|
| Cytoplasm | 3 | 2009 | 1536 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2015 | 1411 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2017 | 372 | 0.080 |
Why?
|
| Synapses | 1 | 2018 | 1728 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1120 | 0.080 |
Why?
|
| DNA-Binding Proteins | 4 | 2008 | 9648 | 0.080 |
Why?
|
| DNA Mutational Analysis | 6 | 2006 | 4183 | 0.080 |
Why?
|
| Astrocytes | 3 | 2011 | 1273 | 0.080 |
Why?
|
| Founder Effect | 3 | 2015 | 189 | 0.080 |
Why?
|
| Adenosine Triphosphate | 4 | 2011 | 2029 | 0.080 |
Why?
|
| Behavior, Animal | 4 | 2013 | 1880 | 0.080 |
Why?
|
| Hybrid Cells | 8 | 1997 | 441 | 0.080 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4204 | 0.080 |
Why?
|
| DNA Probes | 8 | 1993 | 560 | 0.080 |
Why?
|
| Mutant Proteins | 2 | 2011 | 500 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2009 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 727 | 0.080 |
Why?
|
| Apoptosis | 8 | 2010 | 9718 | 0.080 |
Why?
|
| Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
| Stem Cells | 5 | 2006 | 3566 | 0.070 |
Why?
|
| Genes, Viral | 3 | 1987 | 718 | 0.070 |
Why?
|
| Receptors, HIV | 2 | 1999 | 163 | 0.070 |
Why?
|
| Sheep | 1 | 2010 | 1437 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 2110 | 0.070 |
Why?
|
| Inheritance Patterns | 1 | 2009 | 339 | 0.070 |
Why?
|
| Hypertrichosis | 1 | 2007 | 25 | 0.070 |
Why?
|
| Receptor, trkB | 1 | 2007 | 125 | 0.070 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2008 | 200 | 0.070 |
Why?
|
| Human Development | 1 | 2008 | 124 | 0.070 |
Why?
|
| Receptors, Cytokine | 2 | 1999 | 262 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 1994 | 708 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1885 | 0.070 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2006 | 97 | 0.070 |
Why?
|
| Cytochromes c | 2 | 2004 | 180 | 0.070 |
Why?
|
| Neuropeptides | 2 | 2014 | 942 | 0.070 |
Why?
|
| Genome, Human | 8 | 2008 | 4418 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2006 | 17 | 0.070 |
Why?
|
| Cricetinae | 8 | 1997 | 2475 | 0.070 |
Why?
|
| Neurologic Examination | 2 | 2007 | 929 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1940 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2021 | 4041 | 0.070 |
Why?
|
| Quinolinic Acid | 1 | 2006 | 67 | 0.070 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 1179 | 0.070 |
Why?
|
| Phosphorylation | 4 | 2006 | 8436 | 0.070 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2006 | 126 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 10 | 2010 | 6170 | 0.070 |
Why?
|
| Enzyme Activation | 4 | 2006 | 3701 | 0.070 |
Why?
|
| Cadherins | 1 | 2011 | 907 | 0.070 |
Why?
|
| Herbicides | 1 | 2006 | 100 | 0.070 |
Why?
|
| Inclusion Bodies | 3 | 2005 | 279 | 0.070 |
Why?
|
| Multigene Family | 1 | 1989 | 1101 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2007 | 323 | 0.070 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 1981 | 189 | 0.070 |
Why?
|
| Neuroprotective Agents | 3 | 2014 | 941 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2014 | 3622 | 0.070 |
Why?
|
| Polycythemia | 3 | 1981 | 125 | 0.070 |
Why?
|
| Kynurenine | 1 | 2006 | 139 | 0.070 |
Why?
|
| Growth and Development | 1 | 2005 | 52 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2006 | 144 | 0.060 |
Why?
|
| Immunoglobulin Fragments | 1 | 2005 | 84 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2006 | 380 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 1987 | 424 | 0.060 |
Why?
|
| Internet | 3 | 2015 | 3058 | 0.060 |
Why?
|
| Chromosome Deletion | 3 | 2012 | 1396 | 0.060 |
Why?
|
| Rats | 11 | 2014 | 24250 | 0.060 |
Why?
|
| Developmental Disabilities | 2 | 2012 | 1452 | 0.060 |
Why?
|
| Transgenes | 2 | 2010 | 1008 | 0.060 |
Why?
|
| Basal Ganglia Diseases | 1 | 2005 | 148 | 0.060 |
Why?
|
| Chromatin | 2 | 2015 | 2931 | 0.060 |
Why?
|
| Rotarod Performance Test | 2 | 2014 | 64 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2007 | 3000 | 0.060 |
Why?
|
| Alternative Splicing | 3 | 2012 | 1117 | 0.060 |
Why?
|
| Kallmann Syndrome | 1 | 2005 | 140 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1707 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2005 | 425 | 0.060 |
Why?
|
| Aged | 33 | 2021 | 163178 | 0.060 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2004 | 74 | 0.060 |
Why?
|
| Motor Activity | 3 | 2013 | 2714 | 0.060 |
Why?
|
| Transfection | 7 | 2003 | 5892 | 0.060 |
Why?
|
| Electron Transport Complex II | 1 | 2004 | 48 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 514 | 0.060 |
Why?
|
| Biotin | 1 | 2005 | 254 | 0.060 |
Why?
|
| Protein Binding | 4 | 2009 | 9377 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2005 | 250 | 0.060 |
Why?
|
| Neural Pathways | 2 | 2013 | 2971 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2011 | 1800 | 0.060 |
Why?
|
| Body Weight | 1 | 2015 | 4670 | 0.060 |
Why?
|
| Microsatellite Instability | 1 | 2007 | 684 | 0.060 |
Why?
|
| Immunohistochemistry | 8 | 2011 | 11360 | 0.060 |
Why?
|
| Intracellular Membranes | 2 | 2004 | 391 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2006 | 435 | 0.060 |
Why?
|
| Histones | 2 | 2015 | 2598 | 0.060 |
Why?
|
| Chromosomes, Fungal | 6 | 1993 | 111 | 0.060 |
Why?
|
| Chromones | 1 | 2003 | 154 | 0.060 |
Why?
|
| Mitochondria, Liver | 1 | 2004 | 187 | 0.060 |
Why?
|
| Caspases | 3 | 2004 | 928 | 0.060 |
Why?
|
| Axonal Transport | 1 | 2003 | 177 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2006 | 2646 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 707 | 0.050 |
Why?
|
| Introns | 4 | 2006 | 991 | 0.050 |
Why?
|
| Glycoproteins | 4 | 2008 | 2266 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 783 | 0.050 |
Why?
|
| Fibroblasts | 6 | 2017 | 4162 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2006 | 1157 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 2 | 1986 | 1263 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 9 | 2018 | 21824 | 0.050 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2003 | 91 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2010 | 1349 | 0.050 |
Why?
|
| Codon | 2 | 1994 | 611 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 90 | 0.050 |
Why?
|
| Tachykinins | 1 | 2002 | 78 | 0.050 |
Why?
|
| Costa Rica | 1 | 2001 | 177 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2003 | 237 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2005 | 1702 | 0.050 |
Why?
|
| Cell Size | 3 | 2014 | 641 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2002 | 299 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 960 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2007 | 1364 | 0.050 |
Why?
|
| Genes, Reporter | 3 | 2019 | 1545 | 0.050 |
Why?
|
| Cyclin D1 | 1 | 2003 | 463 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1403 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2003 | 430 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 6 | 2006 | 5867 | 0.050 |
Why?
|
| Defective Viruses | 1 | 1981 | 112 | 0.050 |
Why?
|
| Cholesterol | 1 | 2010 | 2922 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2002 | 224 | 0.050 |
Why?
|
| Glutathione Transferase | 2 | 2000 | 595 | 0.050 |
Why?
|
| Somatosensory Cortex | 1 | 2005 | 525 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2021 | 6593 | 0.050 |
Why?
|
| Adolescent | 18 | 2016 | 85729 | 0.050 |
Why?
|
| Clone Cells | 3 | 2000 | 1692 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2010 | 1712 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2017 | 460 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2014 | 5179 | 0.050 |
Why?
|
| Child, Preschool | 11 | 2021 | 40964 | 0.050 |
Why?
|
| Tretinoin | 2 | 2001 | 517 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 491 | 0.050 |
Why?
|
| Branchial Region | 1 | 2000 | 35 | 0.050 |
Why?
|
| Aged, 80 and over | 15 | 2016 | 57744 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2014 | 1709 | 0.050 |
Why?
|
| Education, Professional | 1 | 2000 | 54 | 0.050 |
Why?
|
| Morpholines | 1 | 2003 | 571 | 0.050 |
Why?
|
| Cytosol | 1 | 2003 | 901 | 0.050 |
Why?
|
| Intranuclear Inclusion Bodies | 2 | 2013 | 37 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1723 | 0.050 |
Why?
|
| Cleft Lip | 1 | 2005 | 478 | 0.050 |
Why?
|
| Spliceosomes | 1 | 2000 | 110 | 0.050 |
Why?
|
| Sodium Channels | 2 | 2012 | 349 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2010 | 2327 | 0.040 |
Why?
|
| Cell Survival | 6 | 2011 | 5881 | 0.040 |
Why?
|
| Transglutaminases | 1 | 2001 | 194 | 0.040 |
Why?
|
| Research | 2 | 2002 | 1999 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 1335 | 0.040 |
Why?
|
| Cleft Palate | 1 | 2005 | 560 | 0.040 |
Why?
|
| Cohort Studies | 8 | 2016 | 40545 | 0.040 |
Why?
|
| Liver | 1 | 2015 | 7479 | 0.040 |
Why?
|
| Immune Sera | 1 | 2000 | 641 | 0.040 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1999 | 95 | 0.040 |
Why?
|
| Transferrin | 1 | 2000 | 295 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2003 | 3772 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2006 | 143 | 0.040 |
Why?
|
| Receptors, CCR5 | 2 | 1999 | 498 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 1030 | 0.040 |
Why?
|
| Disease Progression | 6 | 2015 | 13273 | 0.040 |
Why?
|
| Ion Channels | 1 | 2004 | 1056 | 0.040 |
Why?
|
| Thalamus | 1 | 2005 | 1023 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2003 | 558 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2001 | 471 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2000 | 443 | 0.040 |
Why?
|
| RNA Splicing | 2 | 2021 | 907 | 0.040 |
Why?
|
| Spinocerebellar Degenerations | 2 | 1996 | 43 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2003 | 1252 | 0.040 |
Why?
|
| Neocortex | 1 | 2003 | 399 | 0.040 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 1998 | 39 | 0.040 |
Why?
|
| Genetics, Medical | 1 | 2002 | 338 | 0.040 |
Why?
|
| Recombinant Proteins | 5 | 2004 | 6620 | 0.040 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 1998 | 11 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 5 | 1993 | 1374 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2007 | 2649 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1996 | 2123 | 0.040 |
Why?
|
| Child | 12 | 2021 | 77637 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 2916 | 0.040 |
Why?
|
| Mitosis | 2 | 2006 | 1207 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2003 | 2617 | 0.040 |
Why?
|
| Breast Diseases | 1 | 2001 | 443 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 2006 | 1466 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2008 | 1162 | 0.040 |
Why?
|
| Microtubules | 1 | 2004 | 1087 | 0.040 |
Why?
|
| Myotonic Dystrophy | 2 | 1996 | 78 | 0.040 |
Why?
|
| RNA | 2 | 2000 | 2748 | 0.040 |
Why?
|
| beta Catenin | 1 | 2003 | 1060 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3847 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 2134 | 0.040 |
Why?
|
| Autophagy | 1 | 2006 | 1296 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 3591 | 0.040 |
Why?
|
| Erythrocyte Membrane | 2 | 1979 | 442 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2369 | 0.040 |
Why?
|
| Bone Diseases | 1 | 2001 | 416 | 0.040 |
Why?
|
| Endosomes | 1 | 2000 | 518 | 0.040 |
Why?
|
| Lymphocytes | 2 | 2012 | 2615 | 0.040 |
Why?
|
| Erythropoiesis | 2 | 1979 | 706 | 0.040 |
Why?
|
| Sex Characteristics | 3 | 2009 | 2583 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2002 | 1154 | 0.040 |
Why?
|
| Interneurons | 2 | 2005 | 577 | 0.040 |
Why?
|
| Australia | 3 | 2006 | 1167 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2000 | 546 | 0.040 |
Why?
|
| Peptide Initiation Factors | 1 | 1997 | 56 | 0.040 |
Why?
|
| Iron-Binding Proteins | 1 | 1997 | 79 | 0.040 |
Why?
|
| Time Factors | 7 | 2021 | 40038 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2003 | 1055 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2000 | 1962 | 0.040 |
Why?
|
| Friedreich Ataxia | 1 | 1997 | 76 | 0.040 |
Why?
|
| Models, Animal | 1 | 2003 | 2172 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 438 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 3 | 1991 | 170 | 0.040 |
Why?
|
| In Situ Hybridization | 3 | 1996 | 1952 | 0.040 |
Why?
|
| Age Factors | 6 | 2016 | 18355 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 1861 | 0.040 |
Why?
|
| Meiosis | 1 | 1999 | 338 | 0.040 |
Why?
|
| Depressive Disorder, Major | 2 | 2015 | 4635 | 0.040 |
Why?
|
| Genome | 2 | 2003 | 1806 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2566 | 0.040 |
Why?
|
| Species Specificity | 3 | 1998 | 2480 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 1999 | 449 | 0.030 |
Why?
|
| Gait | 1 | 2002 | 795 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2006 | 1787 | 0.030 |
Why?
|
| Cartilage | 1 | 2000 | 818 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1999 | 504 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1998 | 431 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 10629 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2003 | 2927 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 1999 | 670 | 0.030 |
Why?
|
| Hypergammaglobulinemia | 1 | 1975 | 74 | 0.030 |
Why?
|
| Italy | 2 | 1994 | 829 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3794 | 0.030 |
Why?
|
| Portugal | 1 | 2015 | 86 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2002 | 1358 | 0.030 |
Why?
|
| Reference Values | 3 | 2001 | 4974 | 0.030 |
Why?
|
| Nondisjunction, Genetic | 1 | 1994 | 24 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 437 | 0.030 |
Why?
|
| Gaucher Disease | 1 | 1975 | 112 | 0.030 |
Why?
|
| Metaphase | 2 | 1992 | 151 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 19894 | 0.030 |
Why?
|
| Base Pairing | 1 | 2015 | 141 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2504 | 0.030 |
Why?
|
| Computational Biology | 2 | 2010 | 3515 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 2007 | 897 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2004 | 8300 | 0.030 |
Why?
|
| Histological Techniques | 1 | 1995 | 198 | 0.030 |
Why?
|
| Binding Sites | 2 | 2006 | 6111 | 0.030 |
Why?
|
| Fragile X Syndrome | 1 | 1996 | 114 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 1997 | 407 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2419 | 0.030 |
Why?
|
| Protein Conformation | 2 | 1999 | 4009 | 0.030 |
Why?
|
| Lod Score | 3 | 2002 | 613 | 0.030 |
Why?
|
| Hemoglobins | 3 | 1981 | 1531 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4749 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 8035 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2013 | 126 | 0.030 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1994 | 109 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2014 | 331 | 0.030 |
Why?
|
| Greece | 2 | 2006 | 344 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2938 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2003 | 3749 | 0.030 |
Why?
|
| Adenine | 2 | 2011 | 935 | 0.030 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2014 | 199 | 0.030 |
Why?
|
| Amyloid | 1 | 1998 | 795 | 0.030 |
Why?
|
| Mefloquine | 1 | 1993 | 55 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1994 | 351 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 98 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1998 | 1131 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 2014 | 3421 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 3 | 2006 | 2086 | 0.030 |
Why?
|
| Antigens | 1 | 1978 | 1466 | 0.030 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2012 | 29 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 175 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2002 | 1580 | 0.030 |
Why?
|
| Peptide Fragments | 3 | 1999 | 5096 | 0.030 |
Why?
|
| Growth Disorders | 1 | 1997 | 645 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 1997 | 608 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 1999 | 1237 | 0.030 |
Why?
|
| North America | 2 | 2006 | 1249 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1994 | 1581 | 0.030 |
Why?
|
| Chromosome Banding | 2 | 1993 | 278 | 0.030 |
Why?
|
| Cadaver | 2 | 2012 | 1335 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 1993 | 458 | 0.030 |
Why?
|
| Syndrome | 3 | 2007 | 3249 | 0.030 |
Why?
|
| Facial Bones | 1 | 1993 | 201 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 893 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 3504 | 0.030 |
Why?
|
| Spores, Protozoan | 1 | 2011 | 6 | 0.030 |
Why?
|
| Pregnancy | 4 | 2004 | 29140 | 0.030 |
Why?
|
| Smell | 1 | 2013 | 244 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1993 | 450 | 0.030 |
Why?
|
| Methylation | 1 | 2014 | 1104 | 0.020 |
Why?
|
| Chromosome Inversion | 1 | 2012 | 127 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 3706 | 0.020 |
Why?
|
| Microglia | 2 | 2013 | 1267 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 1992 | 290 | 0.020 |
Why?
|
| Face | 1 | 1997 | 993 | 0.020 |
Why?
|
| Cyclosporine | 2 | 2004 | 788 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2011 | 166 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2001 | 1619 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2011 | 151 | 0.020 |
Why?
|
| Calcium | 1 | 2004 | 5755 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1114 | 0.020 |
Why?
|
| Aging | 3 | 2009 | 8655 | 0.020 |
Why?
|
| Mosaicism | 1 | 1993 | 441 | 0.020 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2010 | 52 | 0.020 |
Why?
|
| DNA Primers | 2 | 2011 | 2891 | 0.020 |
Why?
|
| Sterols | 1 | 2010 | 63 | 0.020 |
Why?
|
| Case-Control Studies | 4 | 2012 | 21733 | 0.020 |
Why?
|
| Structure-Activity Relationship | 3 | 2003 | 3128 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2010 | 2725 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2010 | 115 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 329 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 634 | 0.020 |
Why?
|
| History, 19th Century | 1 | 1993 | 720 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 4 | 2003 | 6311 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 2944 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2010 | 199 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2006 | 3130 | 0.020 |
Why?
|
| Probability | 2 | 2007 | 2505 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1995 | 694 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1990 | 211 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1991 | 462 | 0.020 |
Why?
|
| Lysosomes | 2 | 2005 | 893 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2001 | 287 | 0.020 |
Why?
|
| Biological Transport | 2 | 2004 | 2119 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 167 | 0.020 |
Why?
|
| Prevalence | 4 | 2015 | 15211 | 0.020 |
Why?
|
| Ovary | 1 | 2014 | 980 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1994 | 525 | 0.020 |
Why?
|
| Simian virus 40 | 2 | 1987 | 297 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 807 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1997 | 1212 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1998 | 2750 | 0.020 |
Why?
|
| BK Virus | 2 | 1987 | 129 | 0.020 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 1826 | 0.020 |
Why?
|
| Oxygen | 1 | 2000 | 4189 | 0.020 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 143 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1978 | 2455 | 0.020 |
Why?
|
| Family | 2 | 2015 | 3144 | 0.020 |
Why?
|
| Young Adult | 5 | 2016 | 56392 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 326 | 0.020 |
Why?
|
| Cystic Fibrosis | 2 | 1997 | 1178 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2883 | 0.020 |
Why?
|
| Cell Nucleolus | 1 | 2009 | 166 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 2013 | 671 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 3 | 1996 | 3389 | 0.020 |
Why?
|
| Linear Models | 2 | 2015 | 5952 | 0.020 |
Why?
|
| Retroviridae | 2 | 2001 | 913 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2002 | 3264 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 1994 | 903 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 1420 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1996 | 1660 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 2503 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 464 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 48 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2011 | 607 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 765 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2007 | 124 | 0.020 |
Why?
|
| Genes, Regulator | 2 | 1987 | 379 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 3758 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2914 | 0.020 |
Why?
|
| COS Cells | 2 | 2001 | 1161 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 853 | 0.020 |
Why?
|
| Prefrontal Cortex | 2 | 2014 | 2147 | 0.020 |
Why?
|
| Public Health | 1 | 2000 | 2603 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2008 | 193 | 0.020 |
Why?
|
| Parents | 2 | 2007 | 3403 | 0.020 |
Why?
|
| Antigens, Surface | 3 | 1980 | 1663 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 2241 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2011 | 959 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1084 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2011 | 751 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2012 | 851 | 0.020 |
Why?
|
| RNA-Binding Proteins | 2 | 2009 | 1900 | 0.020 |
Why?
|
| Birth Order | 1 | 2007 | 95 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2010 | 546 | 0.020 |
Why?
|
| Social Behavior | 1 | 2013 | 1126 | 0.020 |
Why?
|
| Caenorhabditis elegans | 2 | 2010 | 1417 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 841 | 0.020 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 1986 | 28 | 0.020 |
Why?
|
| Muscles | 1 | 1992 | 1613 | 0.020 |
Why?
|
| Putamen | 1 | 2007 | 291 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10477 | 0.020 |
Why?
|
| Fibrin | 2 | 1986 | 505 | 0.020 |
Why?
|
| Kynurenic Acid | 1 | 2006 | 46 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 652 | 0.020 |
Why?
|
| Telomere | 1 | 1992 | 910 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2006 | 156 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2006 | 344 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 2177 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2006 | 427 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2010 | 646 | 0.020 |
Why?
|
| Turkey | 1 | 2006 | 237 | 0.020 |
Why?
|
| Spleen | 3 | 1981 | 2359 | 0.020 |
Why?
|
| Polyomavirus | 1 | 1987 | 249 | 0.020 |
Why?
|
| Ceroid | 1 | 2005 | 6 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2005 | 22 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2006 | 183 | 0.020 |
Why?
|
| Karyotyping | 3 | 1997 | 1243 | 0.020 |
Why?
|
| Cricetulus | 1 | 1987 | 818 | 0.020 |
Why?
|
| Blotting, Southern | 3 | 1991 | 803 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1993 | 1416 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6356 | 0.020 |
Why?
|
| Glucose | 2 | 2013 | 4398 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2007 | 468 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 240 | 0.020 |
Why?
|
| Gossypol | 1 | 2005 | 23 | 0.020 |
Why?
|
| Guanine | 1 | 2006 | 274 | 0.020 |
Why?
|
| Cytosine | 1 | 2006 | 216 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2006 | 23327 | 0.020 |
Why?
|
| Olfaction Disorders | 1 | 2007 | 222 | 0.020 |
Why?
|
| Gestational Age | 1 | 1993 | 3488 | 0.020 |
Why?
|
| DNA, Recombinant | 4 | 1987 | 476 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2004 | 61 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 349 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2013 | 2307 | 0.020 |
Why?
|
| Seizures | 1 | 1997 | 2850 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1993 | 2736 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2006 | 186 | 0.020 |
Why?
|
| Valine | 1 | 2006 | 413 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 906 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2692 | 0.020 |
Why?
|
| Fathers | 1 | 2007 | 358 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 1436 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2005 | 244 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2005 | 322 | 0.020 |
Why?
|
| Ruthenium Red | 1 | 2004 | 19 | 0.020 |
Why?
|
| Cognition | 1 | 2022 | 6759 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2006 | 528 | 0.020 |
Why?
|
| Uncoupling Agents | 1 | 2004 | 45 | 0.020 |
Why?
|
| MSX1 Transcription Factor | 1 | 2004 | 53 | 0.020 |
Why?
|
| Rotenone | 1 | 2004 | 43 | 0.020 |
Why?
|
| Viral Proteins | 2 | 2003 | 1899 | 0.020 |
Why?
|
| Malaria, Falciparum | 1 | 1993 | 1075 | 0.020 |
Why?
|
| Neuroblastoma | 2 | 2003 | 1226 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 291 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1994 | 1591 | 0.010 |
Why?
|
| Nitro Compounds | 1 | 2004 | 74 | 0.010 |
Why?
|
| Learning | 1 | 2013 | 1710 | 0.010 |
Why?
|
| Decapodiformes | 1 | 2003 | 33 | 0.010 |
Why?
|
| Toxins, Biological | 1 | 2004 | 66 | 0.010 |
Why?
|
| Methionine | 1 | 2006 | 590 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6539 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2004 | 188 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 16674 | 0.010 |
Why?
|
| Infant | 5 | 2012 | 35122 | 0.010 |
Why?
|
| Propionates | 1 | 2004 | 169 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2121 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1986 | 1454 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 545 | 0.010 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2004 | 154 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 1993 | 1730 | 0.010 |
Why?
|
| Siblings | 1 | 2007 | 853 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2004 | 424 | 0.010 |
Why?
|
| Kainic Acid | 1 | 2003 | 199 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2007 | 721 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1186 | 0.010 |
Why?
|
| DNA, Viral | 2 | 1996 | 2226 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2005 | 641 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 9272 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12243 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 2003 | 231 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 1574 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1986 | 772 | 0.010 |
Why?
|
| Calpain | 1 | 2002 | 150 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2002 | 382 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 10940 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2001 | 75 | 0.010 |
Why?
|
| Culture Media | 2 | 1981 | 909 | 0.010 |
Why?
|
| Enkephalins | 1 | 2002 | 154 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 3 | 1988 | 570 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1986 | 1802 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1793 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 2001 | 196 | 0.010 |
Why?
|
| Helper Viruses | 1 | 1981 | 58 | 0.010 |
Why?
|
| Mental Recall | 1 | 2007 | 1206 | 0.010 |
Why?
|
| Genes, p16 | 1 | 2001 | 157 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2004 | 565 | 0.010 |
Why?
|
| Dystonia Musculorum Deformans | 1 | 2001 | 158 | 0.010 |
Why?
|
| Reaction Time | 1 | 2007 | 2091 | 0.010 |
Why?
|
| Leukemia Virus, Murine | 1 | 1981 | 117 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 453 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1981 | 355 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2002 | 318 | 0.010 |
Why?
|
| Polyamines | 1 | 2001 | 120 | 0.010 |
Why?
|
| Zebrafish | 1 | 2012 | 2995 | 0.010 |
Why?
|
| Substance P | 1 | 2002 | 335 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 2 | 1979 | 250 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 2002 | 253 | 0.010 |
Why?
|
| Anemia | 2 | 1980 | 1502 | 0.010 |
Why?
|
| Integrases | 1 | 2003 | 533 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 35409 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1137 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3874 | 0.010 |
Why?
|
| Japan | 1 | 2004 | 1360 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1986 | 1073 | 0.010 |
Why?
|
| Virus Replication | 2 | 1996 | 2535 | 0.010 |
Why?
|
| New England | 1 | 2003 | 1022 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 2000 | 85 | 0.010 |
Why?
|
| Professional Competence | 2 | 2000 | 447 | 0.010 |
Why?
|
| Endocytosis | 1 | 2004 | 985 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1987 | 1344 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1981 | 642 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6457 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2001 | 352 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 1152 | 0.010 |
Why?
|
| Age Distribution | 1 | 2006 | 2899 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 1085 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2001 | 535 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2001 | 1102 | 0.010 |
Why?
|
| International Cooperation | 1 | 2006 | 1419 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 1783 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 2003 | 598 | 0.010 |
Why?
|
| Education, Nursing, Diploma Programs | 1 | 1978 | 11 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1374 | 0.010 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2002 | 476 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2001 | 755 | 0.010 |
Why?
|
| Anxiety | 1 | 2013 | 4288 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2001 | 657 | 0.010 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 1978 | 22 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2006 | 1640 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 12954 | 0.010 |
Why?
|
| Hemin | 1 | 1978 | 50 | 0.010 |
Why?
|
| HIV-1 | 1 | 1996 | 6939 | 0.010 |
Why?
|
| TATA Box | 1 | 1998 | 128 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 705 | 0.010 |
Why?
|
| Dopamine | 1 | 2006 | 1592 | 0.010 |
Why?
|
| Industry | 1 | 2000 | 366 | 0.010 |
Why?
|
| Ouabain | 1 | 1978 | 264 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2000 | 983 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 574 | 0.010 |
Why?
|
| Sex Factors | 2 | 2007 | 10394 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 1999 | 212 | 0.010 |
Why?
|
| Survival Rate | 2 | 2003 | 12786 | 0.010 |
Why?
|
| Movement Disorders | 1 | 2001 | 448 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 1999 | 171 | 0.010 |
Why?
|
| Neural Crest | 1 | 2000 | 275 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1729 | 0.010 |
Why?
|
| Netherlands | 1 | 2002 | 2170 | 0.010 |
Why?
|
| Environment | 1 | 2004 | 1121 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2015 | 5027 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9848 | 0.010 |
Why?
|
| Attention | 1 | 2007 | 2393 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 1263 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 2890 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 4665 | 0.010 |
Why?
|
| Blood Donors | 1 | 1999 | 355 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1997 | 146 | 0.010 |
Why?
|
| Acetamides | 1 | 1978 | 248 | 0.010 |
Why?
|
| G-Protein-Coupled Receptor Kinase 4 | 1 | 1996 | 3 | 0.010 |
Why?
|
| Mothers | 1 | 2007 | 2166 | 0.010 |
Why?
|
| Touch | 1 | 1999 | 304 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 1997 | 107 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1981 | 726 | 0.010 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1987 | 156 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1996 | 54 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 5445 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1980 | 1035 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 2017 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1980 | 1266 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 3338 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1997 | 440 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1677 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 9858 | 0.010 |
Why?
|
| New South Wales | 1 | 1994 | 66 | 0.010 |
Why?
|
| Risk Factors | 3 | 2012 | 72252 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1202 | 0.010 |
Why?
|
| Potassium | 1 | 1979 | 1336 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3712 | 0.010 |
Why?
|
| Chemokines | 1 | 1999 | 968 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77410 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 1994 | 16 | 0.010 |
Why?
|
| Sperm Banks | 1 | 1994 | 7 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 1994 | 27 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2009 | 5100 | 0.010 |
Why?
|
| Program Development | 1 | 2000 | 1314 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 2047 | 0.010 |
Why?
|
| Tissue Banks | 1 | 1995 | 184 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 1999 | 727 | 0.010 |
Why?
|
| Homosexuality | 1 | 1994 | 262 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 1993 | 27 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1994 | 448 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2000 | 1210 | 0.010 |
Why?
|
| Respiratory System | 1 | 1997 | 557 | 0.010 |
Why?
|
| Protons | 1 | 1998 | 1129 | 0.010 |
Why?
|
| Testis | 1 | 1996 | 795 | 0.010 |
Why?
|
| Placenta | 1 | 2001 | 1699 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 1577 | 0.010 |
Why?
|
| Ear, External | 1 | 1993 | 161 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1997 | 1063 | 0.010 |
Why?
|
| Narcotics | 1 | 1994 | 343 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 1992 | 112 | 0.010 |
Why?
|
| Antibodies | 1 | 1980 | 2459 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1999 | 852 | 0.010 |
Why?
|
| Thailand | 1 | 1993 | 299 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2012 | 25609 | 0.010 |
Why?
|
| Amino Acids | 1 | 1998 | 1733 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15067 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 13980 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3082 | 0.010 |
Why?
|
| Plasmids | 2 | 1987 | 2308 | 0.010 |
Why?
|
| HIV | 1 | 1999 | 1604 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 1999 | 14714 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1997 | 1539 | 0.010 |
Why?
|
| Nucleotides | 1 | 1993 | 463 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 4152 | 0.010 |
Why?
|
| Hernia, Inguinal | 1 | 1993 | 209 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 3917 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1996 | 1079 | 0.010 |
Why?
|
| HIV Infections | 1 | 1996 | 16715 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1995 | 671 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1990 | 90 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15526 | 0.010 |
Why?
|
| Fluorescence | 1 | 1992 | 752 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 1993 | 371 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1991 | 354 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 1992 | 600 | 0.010 |
Why?
|
| Hippocampus | 1 | 2001 | 3672 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1988 | 31 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15142 | 0.000 |
Why?
|
| Confidence Intervals | 1 | 1993 | 2971 | 0.000 |
Why?
|
| MNSs Blood-Group System | 1 | 1986 | 8 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1993 | 1606 | 0.000 |
Why?
|
| Equipment Design | 1 | 1995 | 3574 | 0.000 |
Why?
|
| Plasminogen Inactivators | 1 | 1986 | 38 | 0.000 |
Why?
|
| Central Nervous System Stimulants | 1 | 1994 | 1148 | 0.000 |
Why?
|
| Gastroesophageal Reflux | 1 | 1993 | 782 | 0.000 |
Why?
|
| Plasminogen | 1 | 1986 | 152 | 0.000 |
Why?
|
| Vitamin D-Binding Protein | 1 | 1986 | 129 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1996 | 2961 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1997 | 10251 | 0.000 |
Why?
|
| Endothelium | 1 | 1986 | 777 | 0.000 |
Why?
|
| Neoplasms | 1 | 2012 | 21675 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1997 | 6622 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 10179 | 0.000 |
Why?
|
| Kidney | 2 | 1987 | 7185 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1980 | 366 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1980 | 517 | 0.000 |
Why?
|
| Globins | 1 | 1979 | 416 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1993 | 12354 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13691 | 0.000 |
Why?
|
| United States | 2 | 2002 | 69859 | 0.000 |
Why?
|
| Major Histocompatibility Complex | 1 | 1980 | 936 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1993 | 4584 | 0.000 |
Why?
|
| Incidence | 1 | 1993 | 20948 | 0.000 |
Why?
|
| Sodium | 1 | 1979 | 1622 | 0.000 |
Why?
|
| Neoplastic Stem Cells | 1 | 1981 | 1376 | 0.000 |
Why?
|
| Skin | 1 | 1987 | 4372 | 0.000 |
Why?
|
| Kinetics | 1 | 1980 | 6476 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1980 | 2901 | 0.000 |
Why?
|
| Hematopoiesis | 1 | 1980 | 2073 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1994 | 53250 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1980 | 2942 | 0.000 |
Why?
|